Seres Therapeutics Stock Forecast

Sell candidate since Jul 16, 2026 Loss -7.34%

The Seres Therapeutics stock price fell by -1.03% on the last day (Tuesday, 28th Jul 2026) from $4.85 to $4.80. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 9.15% from a day low at $4.59 to a day high of $5.01. The price has fallen in 6 of the last 10 days and is down by -10.03% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -4 thousand shares and in total, 63 thousand shares were bought and sold for approximately $303.83 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $4.45 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -24.61% during the next 3 months and, with a 90% probability hold a price between $3.36 and $5.68 at the end of this 3-month period.

MCRB Signals & Forecast

There are few to no technical positive signals at the moment. The Seres Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $5.07 and $6.28. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, July 07, 2026, and so far it has fallen -41.03%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Seres Therapeutics stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.420 between high and low, or 9.15%. For the last week the stock has had daily average volatility of 6.08%.

Seres Therapeutics is oversold on RSI14 (14). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (MCRB) For The Upcoming Trading Day Of Wednesday 29th

For the upcoming trading day on Wednesday, 29th we expect Seres Therapeutics to open at $4.80, and during the day (based on 14 day Average True Range), to move between $4.55 and $5.05, which gives a possible trading interval of +/-$0.496 (+/-10.90%) up or down from last closing price. If Seres Therapeutics takes out the full calculated possible swing range there will be an estimated 10.90% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $5.18, some $0.380 (7.92%) from the current price of $4.80, our system finds the risk reward not very attractive.

Is Seres Therapeutics stock A Buy?

Seres Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -6.871 Strong Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 29, 2026 - $4.80 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk